Eisai
4523.T
#1451
Rank
$11.80 B
Marketcap
$41.17
Share price
-1.41%
Change (1 day)
-26.23%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023 (TTM): $0.52 B

According to Eisai's latest financial reports the company's current earnings (TTM) are $0.52 B. In 2022 the company made an earning of -$22.86 M a decrease over its 2021 earnings that were of $0.63 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023 (TTM)$0.52 B-2392.87%
2022-$22.86 M-103.6%
2021$0.63 B-39.52%
2020$1.04 B7.3%
2019$0.97 B17.23%
2018$0.83 B86.06%
2017$0.44 B-23.64%
2016$0.58 B27.28%
2015$0.46 B22.08%
2014$0.37 B-46.11%
2013$0.70 B-21.67%
2012$0.89 B-20.72%
2011$1.13 B-8.44%
2010$1.23 B18.85%
2009$1.03 B